ES2019826A6 - Procedimiento de preparacion de derivados quinazolinos. - Google Patents

Procedimiento de preparacion de derivados quinazolinos.

Info

Publication number
ES2019826A6
ES2019826A6 ES9001130A ES9001130A ES2019826A6 ES 2019826 A6 ES2019826 A6 ES 2019826A6 ES 9001130 A ES9001130 A ES 9001130A ES 9001130 A ES9001130 A ES 9001130A ES 2019826 A6 ES2019826 A6 ES 2019826A6
Authority
ES
Spain
Prior art keywords
preparation
quinazoline derivatives
derivative
procedure
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES9001130A
Other languages
English (en)
Spanish (es)
Inventor
Josef Reiter
Laszlo Pongo
Frigyes Gorgenyi
Marton Fekete
Margit Csorgo
Ilona Sztuhar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Egyt Gyogyszervegyeszeti Gyar
Egis Pharmaceuticals PLC
Original Assignee
Egyt Gyogyszervegyeszeti Gyar
Egis Pharmaceuticals PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from HU193089A external-priority patent/HU203333B/hu
Priority claimed from HU193189A external-priority patent/HU203342B/hu
Application filed by Egyt Gyogyszervegyeszeti Gyar, Egis Pharmaceuticals PLC filed Critical Egyt Gyogyszervegyeszeti Gyar
Publication of ES2019826A6 publication Critical patent/ES2019826A6/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/18—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ES9001130A 1989-04-21 1990-04-20 Procedimiento de preparacion de derivados quinazolinos. Expired - Lifetime ES2019826A6 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU193089A HU203333B (en) 1989-04-21 1989-04-21 Process for producing n-cyano-carboxamidine derivatives
HU193189A HU203342B (en) 1989-04-21 1989-04-21 Process for producing quinazoline deivatives

Publications (1)

Publication Number Publication Date
ES2019826A6 true ES2019826A6 (es) 1991-07-01

Family

ID=26317437

Family Applications (1)

Application Number Title Priority Date Filing Date
ES9001130A Expired - Lifetime ES2019826A6 (es) 1989-04-21 1990-04-20 Procedimiento de preparacion de derivados quinazolinos.

Country Status (16)

Country Link
JP (1) JPH02292282A (en, 2012)
KR (1) KR900016194A (en, 2012)
AT (1) AT398075B (en, 2012)
BG (1) BG91821A (en, 2012)
CA (2) CA2028953A1 (en, 2012)
CH (1) CH681300A5 (en, 2012)
DK (1) DK99090A (en, 2012)
ES (1) ES2019826A6 (en, 2012)
FI (1) FI902002A7 (en, 2012)
GB (1) GB2231571B (en, 2012)
GR (1) GR900100294A (en, 2012)
IT (1) IT1241128B (en, 2012)
PL (1) PL162976B1 (en, 2012)
RU (1) RU1838309C (en, 2012)
SE (1) SE9001402L (en, 2012)
YU (1) YU70890A (en, 2012)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2096518A1 (es) * 1994-03-28 1997-03-01 Almirall Lab Nuevas anilinas.

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2077252C (en) * 1992-08-31 2001-04-10 Khashayar Karimian Methods of making ureas and guanidines, and intermediates therefor
WO2008015525A2 (en) * 2006-07-31 2008-02-07 Orchid Chemicals & Pharmaceuticals Limited An improved process for the preparation of alfuzosin hydrochloride
US20100174073A1 (en) 2007-05-04 2010-07-08 Actavis Group Ptc Ehf Process for the preparation of alfuzosin and salts thereof
US8716476B2 (en) 2007-08-02 2014-05-06 Cipla Limited Process for the preparation of alfuzosin hydrochloride

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4026894A (en) * 1975-10-14 1977-05-31 Abbott Laboratories Antihypertensive agents
US4044135A (en) * 1975-10-14 1977-08-23 Abbott Laboratories Antihypertensive agents
GB1591490A (en) * 1977-08-04 1981-06-24 Abbott Lab 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-tetrahydrofuroyl)piperazine hydrochloride dihydrate
US4138561A (en) * 1977-09-30 1979-02-06 Bristol-Myers Company Cyanocarboxamidines and quinazoline process
FI57751C (fi) * 1977-10-25 1980-10-10 Fermion Oy Foerfarande foer framstaellning av 6,7-dimetoxi- eller 6,7,8-trimetoxi-4-amino-2-(4-substituerade-piperazin-1-yl)-kinazoliner med blodtryckssaenkande verkan
FI56836C (fi) * 1977-10-25 1980-04-10 Fermion Oy 4-substituerade piperazin-1-(n-aryl-n'-cyano)-karboximidamider som aer mellanprodukter vid framstaellningen av farmakologiskt vaerdefulla 6,7-dimetoxi- eller 6,7,8-trimetoxi-4-amino-2-(4-substituerade-piperazin-1-yl)-kinazoliner
FR2421888A1 (fr) * 1978-02-06 1979-11-02 Synthelabo Amides d'alkylene-diamines et leur application en therapeutique
FI59800C (fi) * 1979-01-10 1981-10-12 Fermion Oy Foerfarande foer framstaellning av 6,7-dimetoxi-4-amino-2-(4-(furo-2-yl)-piperazin-1-yl)-kinazolin
FI67699C (fi) * 1979-01-31 1985-05-10 Orion Yhtymae Oy Foerfarande foer framstaellning av 6,7-dimetoxi-4-amino-2-(4-(2-furoyl)-1-piperazinyl)kinazolinhydroklorid med blodtryckssaenkande verkan
ATE32074T1 (de) * 1983-11-22 1988-02-15 Heumann Ludwig & Co Gmbh Verfahren zur herstellung von 4-amino-6,7dimethoxy-2-(4-(furo-2-yl)-piperazin-1-yl)chinazolin und dessen physiologisch annehmbarer salze.

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2096518A1 (es) * 1994-03-28 1997-03-01 Almirall Lab Nuevas anilinas.

Also Published As

Publication number Publication date
RU1838309C (ru) 1993-08-30
PL162976B1 (pl) 1994-01-31
GB9008941D0 (en) 1990-06-20
IT9020092A0 (it) 1990-04-20
YU70890A (en) 1992-05-28
BG91821A (bg) 1993-12-24
CA2015066A1 (en) 1990-10-21
PL284860A1 (en) 1991-03-11
JPH02292282A (ja) 1990-12-03
IT1241128B (it) 1993-12-29
GB2231571B (en) 1992-09-16
FI902002A7 (fi) 1990-10-22
CA2028953A1 (en) 1990-10-22
IT9020092A1 (it) 1991-10-20
KR900016194A (ko) 1990-11-12
GB2231571A (en) 1990-11-21
ATA93190A (de) 1994-01-15
AT398075B (de) 1994-09-26
GR900100294A (el) 1991-09-27
DK99090A (da) 1990-10-22
CH681300A5 (en, 2012) 1993-02-26
DK99090D0 (da) 1990-04-20
SE9001402D0 (sv) 1990-04-20
SE9001402L (sv) 1990-10-22
FI902002A0 (fi) 1990-04-20

Similar Documents

Publication Publication Date Title
ES2172734T3 (es) Intermediarios para la preparacion de compuestos benzoheterociclicos.
PE10290A1 (es) Procedimiento de preparacion de derivados de benzotriazol
ES2054872T3 (es) Nuevos derivados de acido bencimidazolin-2-oxo-1-carboxilico utiles como antagonistas de los receptores 5-ht.
ES2053508T3 (es) Compuestos de acidos 3-pirrolidinil-tio-1-azabiciclo(3.2.0)hept-2-eno-2-carboxilicos.
AR004516A1 (es) Derivados de pirimidina, su uso, procedimientos para prepararlos y medicamentos que los contienen
ES2112332T3 (es) Derivados de substitucion de oxigeno de productos de adicion de nucleofilo-oxido nitrico utilizados como promedicamentos donadores de oxido nitrico.
ES2051719T3 (es) Un procedimiento para producir un compuesto de benzoilurea.
ES8107201A1 (es) Un procedimiento para la preparacion de derivados de morfo- lina
PT91336A (pt) Processo para a preparacao de derivados lactamicos
MX9602979A (es) Compuestos heterociclicos terapeuticos.
ES2019826A6 (es) Procedimiento de preparacion de derivados quinazolinos.
MX9605366A (es) Derivados de amidina biciclicos como inhibidores de la oxido nitrico sintetasa.
ES8507536A1 (es) Un procedimiento para la preparacion de estimulantes cardiacos de quinazolinas.
ES2059626T3 (es) Nuevos esteres de estramustina.
AR026209A1 (es) Compuestos monociclicos basicos con accion nk-2 antagonista, procesos de fabricacion y formulas que los contienen
AR008244A1 (es) Compuestos heterociclicos, procedimiento para prepararlos, composiciones farmaceuticas que los comprenden, uso de dichos compuestos en la fabricacion de medicamentos, e intermediarios utiles en la preparacion de dichos compuestos
SE9003973L (sv) Glycerol, ett framstaellningsfoerfarande foer desamma samt terapeutiska kompositioner innehaallande dem
ES2060958T3 (es) Un derivado de cicloalcanol sustituido con azol, un procedimiento para producirlo y un uso del derivado como un fungicida agricola y horticola.
ES2053471T3 (es) Empleo de dihidropiridinas condensadas carbociclica y heterociclicamente para la preparacion de agentes cardioprotectores, asi como nuevas dihidropiridinas condensadas heterociclica y carbociclicamente, procedimiento para su preparacion y etapas intermedias para su preparacion.
ES2077042T3 (es) Derivados de benzoxazina, derivados de benzotiazina y herbicidas que comprenden los mismos.
EA199900043A1 (ru) ПРОИЗВОДНЫЕ ПИРИДИЛКАРБАМОИЛИНДОЛИНОВ В КАЧЕСТВЕ АНТАГОНИСТОВ 5-НТ2с-РЕЦЕПТОРОВ
MX15697A (es) Derivados heterotetraciclicos de lactama y procesopara su preparacion
MX9305300A (es) Nuevos derivados de 3-oxadiazolil-1-6-naftiridina y proceso para supreparacion.
ES8600254A1 (es) Un procedimiento para preparar derivados de aminopirimidinona
ES2001006A4 (es) Compuestos sustituidos de 2,6-piridina sustituida

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19990405